Best Traditional Pharmaceuticals Companies in England, United Kingdom
The 64 best Traditional Pharmaceuticals companies in England, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Archimedes Pharma.
Our analysis of 50 Traditional Pharmaceuticals companies
$3.2b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2016.
Ranked: Best Traditional Pharmaceuticals companies in England
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Archimedes Pharma Developer of generic pharmaceuticals | $100M | 195 mo ago | Acquired | Jeffrey Buchalter ex-CEO | 2004 | — | — | — |
| 2 | Speciality European Pharma Developer of medicines for urological conditions | $49M | 121 mo ago | Acquired | — | 2006 | — | — | — |
| 3 | Alliance International consumer healthcare business managing brands and partnerships | $45M | 96 mo ago | Public | Peter Butterfield CEO | 1998 | AzureCloudflarejQuery+7 | 15 patents Food processing (chocolate formulation) and financial trading/liquidity management software platforms. | — |
| 4 | Quantum Pharmaceutical Manufacturer of unlicensed medicines | $18M | 116 mo ago | Acquired | — | 2004 | WordPressMySQLPHP+27 | — | 1 job opening |
| 5 | Quantum Pharma Group Manufacturer of drugs | $18M | 116 mo ago | Acquired | Andrew Matthews CEO & MD | 2004 | — | — | — |
| 6 | Gelemetix Provider of non-invasive alternatives to surgery non-invasive alternatives to surgery for chronic low back… | $12M | 61 mo ago | Series C | — | 2012 | — | — | — |
| 7 | Focus Pharmaceuticals Provider of geospatial data and aerial imagery services | $4M | — | Acquired | Mark Cresswell CEO & MD | 2002 | — | — | — |
| 8 | Ridge Pharma Marketer of branded prescription medicines for unmet needs | $4M | 93 mo ago | Series A | — | 2017 | WordPressMySQLSalesforce+16 | — | — |
| 9 | Intrapharm Labs OTC products manufacturer and supplier | $3M | 141 mo ago | Acquired | Kevin James CEO & Chairman | 1999 | — | — | — |
| 10 | Auralis UK-based generic pharma company | $2M | 194 mo ago | Deadpooled | Claude Nash CEO | 2005 | — | — | — |
| 11 | CoM3D Manufacturer of pharmaceuticals and 3D printing formulations | $1M | 72 mo ago | Seed | — | 2019 | — | — | — |
| 12 | RBT Manufacturer and seller of drugs | $115K | 103 mo ago | Funding Raised | Christine Brander Founder & CEO | 2008 | — | — | — |
| 13 | Flarin Manufacturer of joint pain drugs | — | 34 mo ago | Series A | — | 2012 | WordPressMySQLPHP+26 | — | 1 launch |
| 14 | Adrestia Manufacturer of drugs for multiple therapeutic areas | — | 66 mo ago | Acquired | Will Lewis CEO | 2018 | — | — | — |
| 15 | Aero Pharma Pharmaceutical manufacturing company with 51-200 employees, offering a wide range of products like lipsticks… | — | — | Deadpooled | Natha Gharat Owner | 1983 | — | — | — |
| 16 | Amdipharm Mercury Provider of diversified portfolio of off-patent drugs | — | — | Acquired | John Beighton CEO | 2013 | — | — | — |
| 17 | Aspire Pharma Manufacturer of therapeutic drugs and medical devices | — | — | Acquired | Richard Condon Chief Executive Officer | 2009 | WordPressPleskApple iCloud Mail+13 | — | — |
| 18 | Atlanta Biological Manufacturer of generic and branded pharmaceutical products | — | — | Unfunded | — | 2011 | — | — | — |
Top 12 Traditional Pharmaceuticals companies in England
#1
Series C · Macclesfield, England · founded 2012 · 9 employees$11.6Mraised▾
Gelmetix develops gel-based, non-invasive, therapeutic biomaterial medical device. The device is meant to be an alternative to surgery. The company focuses on conditions such as chronic low back pain and osteoarthritis.
- May 2021Series C$7M
- 2020Grant (prize money)—
- Nov 2018Series B$3.9M
- 2015Seed$660K
#2
Acquired · London, England · founded 2006 · 41 employees$49Mraised▾
Specialty european pharma is engaged in the development of products for the treatment of urological conditions. It has its commercial operations in the UK, Germany, France, Italy and the Nordic region. Product brands marketed include bulkamid, mitocin, regurin, uraplex, and aquamid
- May 2016PE—
- Jan 2015Series B$5.6M
- Jul 2008Series B$23.9M
- Feb 2007Series A$19.4M
#3
Public · Chippenham, England · founded 1998 · 249 employees$45.1Mraised▾
International consumer healthcare business managing brands and partnerships. It operates by leveraging collaborations to maximize brand and business performance. The company supports its brands through various functions, including marketing, supply chain management, and scientific affairs. It fosters internal growth by providing opportunities for employee development and advancement. The business focuses on achieving growth for its shareholders through increased margins and strategic investments. A key aspect is the development and execution of a sustainability strategy.
- Jun 2018Post IPO$45.1M
#4
Acquired · Reading, England · founded 2004 · 23 employees$100Mraised▾
Archimedes Pharma Limited operates as a specialty pharmaceutical company. Its products include Gliadel, for high-grade glioma, Zomorph, an oral sustained release morphine product for cancer pain, Nozinan that treats nausea and vomiting in cancer patients, Pabrinex, a formulation of vitamins B and C for alcoholics experiencing acute withdrawal, and Nasalfent, intranasal fentanyl for the relief of cancer pain.
- Mar 2010Series C$97.6M
#5
Acquired · Durham, England · founded 2004 · 218 employees$18.4Mraised▾
Manufacturer of unlicensed medicines
- Oct 2016Post IPO$18.4M
#6
Acquired · Durham, England · founded 2004$18.3Mraised▾
Manufacturer of drugs
- Oct 2016Post IPO$18.3M
#7
Seed · Brighton, England · founded 2019 · 3 employees$1.2Mraised▾
Manufacturer of pharmaceuticals and 3D printing formulations
- Jun 2020Seed$1.2M
#8
Series A · Reading, England · founded 2017 · 9 employees$4.1Mraised▾
Marketer of branded prescription medicines for unmet needs. This company focuses on the marketing and distribution of branded prescription medications addressing underserved therapeutic areas. It builds strategic partnerships to expand its product portfolio and enhance market access. The company prioritizes providing quality medicines with added support at exceptional value to stakeholders. A commitment to sustainable business practices and ethical conduct guides its operations.
- Sep 2018Series A$4.1M
#9
Acquired · London, England · founded 2002 · 25 employees$4.4Mraised▾
Provider of geospatial data and aerial imagery services. This includes aerial photography, scan services for analog images, and aerotriangulation. They also create and process geospatial data, offering orthophotos, topographic maps, 3D terrain models derived from aerial or laser scan data, and 3D city models. Further services encompass specialized geospatial data such as green space inventories, property records with outdoor facilities, and solar potential analyses based on 3D models or laser scan data. WebGIS solutions for data visualization and analysis are also provided.
- Series A$4.4M
#10
Acquired · Cookham, England · founded 1999 · 13 employees$3.3Mraised▾
Intrapharm Laboratories is a speciality pharmaceutical focussed on the manufacturing and supply of OTC products to both the UK and Republic of Ireland. It has provided services for the supply of pharmaceutical products with proven therapeutic value and medical need addressing therapeutic areas covering oncology, ophthalmology, pain, gastrointestinal and dermatology. Its products include Lactulose Sachets, Terra Cortril, Carbocisteine Sachets, Triamcinolone Hexacetonide, Naltrexone Implants and Generics. In November 2015, Riemser Pharma acquired Intrapharm Laboratories.
- Sep 2014Conventional Debt—
- Aug 2014Series A$3.3M
#11
Deadpooled · Halton, England · founded 2005 · 3 employees$2.2Mraised▾
Auralis was a UK-based generic pharma company. It was acquired by Viro Pharma in 2010. Auralis works on therapeutic areas of critical care, pediatrics, and addiction. It manufactures of injections and powder for reconstitution for injections.
- Apr 2010Seed$2.2M
#12
Funding Raised · Daventry, England · founded 2008$115.3Kraised▾
Manufacturer and seller of drugs
- Oct 2017Grant (prize money)$58.1K
- Jul 2017Grant (prize money)$57.1K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Traditional Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding rising · growth rising
What England researches in drug discovery
- Genomics England18
- University of New England4
- New England Biolabs2
- Phoenix Houses of New England1
- New England College1
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.